Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DW-2282: active enantiomer of DW-2143 and potent antitumor agent

Sep. 4, 1998

Label expansion recommended for Photofrin in U.S.

Sep. 4, 1998

Genetix awarded grant for antiangiogenic gene therapy development

Sep. 4, 1998

Clinical trials commence for Calydon's viral therapeutic for prostate cancer

Sep. 4, 1998

FDA approves Gemzar for first-line treatment of non-small cell lung cancer

Sep. 4, 1998

Coadministration of PNU-156765 and antiandrogen for prostate cancer

Sep. 4, 1998

A reduced deacetylated metabolite of FK-317 is responsible for antitumor activity

Sep. 4, 1998

Receptor-selective retinoids under study at BMS

Sep. 3, 1998

Cytotoxic gigantecin analogue presented at ACS meeting

Sep. 3, 1998

WHI reports design, synthesis and pharmacological evaluation of new agent for glioblastoma

Sep. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...